Search for: "Eli Lilly "
Results 961 - 980
of 2,131
Sorted by Relevance
|
Sort by Date
5 Nov 2006, 8:29 pm
Teva Gemzar--Eli Lilly v. [read post]
31 May 2011, 4:56 pm
In 2009 Eli Lilly paid $1.4 billion for crossing the line in marketing Zyprexa (olanzapine) and Pfizer paid $2.3 billion for illegal marketing of Bextra (valdecoxib). [read post]
20 Mar 2007, 11:21 am
., Eli Lilly & Co., GlaxoSmithKline PLC, Bayer Corp. and Hoffman-LaRoche Inc. [read post]
16 Jan 2009, 10:40 am
In a related issue, Eli Lilly, the manufacturer of Zyprexa, agreed to a $1.4 billion settlement on criminal and civil charges that it illegally marketed Zyprexa by promoting its use in children and the elderly to treat "disruptive" children and to use in nursing home patients to reduce "nursing time and effort" i.e. keep the old people quiet. [read post]
14 Sep 2010, 11:01 am
From news release titled "Lilly, Baker & Daniels Take Civil Law to High School Students" (Inside Indiana Business):Eli Lilly and Company, in collaboration with Baker & Daniels LLP, has launched a program at Indianapolis’ Shortridge Magnet High School for Law & Public Policy to help high school students learn real-world application of civil law. [read post]
19 Apr 2017, 2:21 am
By way of recap, the outline facts of this case are that Eli Lilly hold a patent with a Swiss form claim relating to the use of pemetrexed, in a disodium salt, in combination with vitamin B12 for inhibiting tumour growth. [read post]
23 May 2012, 7:14 am
Like in October 2008, when Eli Lilly settled with 33 state AG’s over Lilly’s marketing of the anti-psychotic drug Zyprexa. [read post]
14 Jan 2010, 11:09 am
Eli Lilly and Company v. [read post]
23 May 2012, 7:14 am
Like in October 2008, when Eli Lilly settled with 33 state AG’s over Lilly’s marketing of the anti-psychotic drug Zyprexa. [read post]
27 Feb 2020, 8:21 am
Eli Lilly and Company, SCT Docket No. [read post]
23 Mar 2021, 1:35 pm
Specifically, besides Xeljanz there are two other JAK inhibitors approved by the FDA: Olumiant (baricitinib) from Eli Lilly & Co.; and, Rinvoq (upadacitinib) from AbbVie. [read post]
9 May 2017, 4:42 am
Subsequently, the CJEU held in Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc [EU: C:2013:835] that Article 3(a) must be interpreted as meaning that it was not necessary for the active ingredient to be identified in the claim by means of a structural formula. [read post]
27 Aug 2018, 4:01 am
But surprisingly, it also had an op-ed calling out Eli Lilly for taking it too far when dropping Conor Daly. [read post]
9 Aug 2011, 8:24 pm
’s (collectively, “Teva”) motion to quash and/or limit the subpoenas duces tecum and ad testificandum issued upon application of Complainant Eli Lilly and Company (“Lilly”). [read post]
11 Oct 2018, 12:57 am
Here the court agreed with MSD’s appeal in that the HIPO’s interpretation of the Eli Lilly judgment was wrong: it does not follow from this judgment that the concerned active ingredient should be mentioned by name or by structure in the description. [read post]
24 Sep 2008, 3:26 pm
I tip my blogger’s hat to Eli Lilly. [read post]
19 Jul 2011, 6:03 am
Here's the list for 2011 so far: Potential Signals of Serious Risks/New Safety Information Identified by AERS, January to March 2011 Product Potential Signal of a Serious Risk/New Safety Information Additional Information (as of May 31, 2011) … [read post]
22 Jan 2010, 12:23 pm
Third, going off something Matt argued: Are businesses (especially large GM/Disney/Eli Lilly types) going to engage in candidate electioneering (as opposed to issue advertising)? [read post]
12 Apr 2008, 3:57 pm
Just to get an idea of how big this issue is, Eli Lilly, who voluntarily started reporting this type of information last year (thank you Eli Lilly), gave almost $19 million in one quarter of 2007 for these "grants" as they refer to them. [read post]
7 Nov 2007, 6:57 pm
”You can read the Order, dated August 17th, 2007, on Acquirelaw™ at In re Eli Lilly & Co. [read post]
